TNFAIP3 mutation is an independent poor overall survival factor for patients with T‐cell acute lymphoblastic leukemia

BACKGROUND: It is imperative to explore potential biomarkers for predicting clinical outcome and developing targeted therapies for T‐cell acute lymphoblastic leukemia (T‐ALL). This study aimed to investigate the mutation patterns of tumor necrosis factor‐alpha‐inducing protein 3 (TNFAIP3, also known...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Cunte, Zhou, Lingling, Zhu, Lihua, Luo, Gengxin, Wang, Liang, Zeng, Chengwu, Zhou, Hongsheng, Li, Yangqiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972139/
https://www.ncbi.nlm.nih.gov/pubmed/36056685
http://dx.doi.org/10.1002/cam4.5196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972139/
https://www.ncbi.nlm.nih.gov/pubmed/36056685
http://dx.doi.org/10.1002/cam4.5196

Ejemplares similares